glp 1 from weight watchers GLP-1 program priorities on app WeightWatchers' stock soars after adding
Description
have divulged glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 1 diabetes, atherosclerosis, type 2 diabetes, obesity, nonalcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH), hypertension, diabetic complications and coronary heart disease among others
These findings may aid clinicians to anticipate and manage these side effects earlier, especially in patients with baseline hypersomnia or sleep related disorders
)
In the EXAMI study, Bernink et al
)
RazaviNematollahi L
Available from: Esposito S, Vanni D, Menta S, Orsatti L, Monteagudo E
